Organization | Trust for Vaccines and Immunization, Pakistan

Trust for Vaccines and Immunization, Pakistan Report issue

Foundation Phase 3 Phase 4

Organization Overview

First Clinical Trial

2013

NCT01908114

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2024

Timeline

NOW

Now

Alternative names

Trust for Vaccines and Immunization, Pakistan | Trust for Vaccines & Immunization (TVI)

Active Ingredients

Drugs in Phase 4 Trials (2)

bivalent oral polio vaccine (bopv), type 1 and type 3 (BOPV) (1 trial)

polio, inactivated poliovirus vaccine (Salk Vaccine) (1 trial)

Drugs in Phase 3 Trials (1)

metformin (glucophage) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Poliomyelitis (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 2
# of Trial APIs: 3